Because osteosarcoma is heterogeneous, we suggest measuring all three types of markers at the beginning of treatment (marker of natural immunity as major, marker of thyroid hormone status as minor, and marker of bone tumor angiogenesis as additional). Here, TG is linked to osteosarcoma.